Ireland· IE-PA-PA1009/004/001
GLYPRESSIN 1 mg Powder and Solvent for Solution for Injection
A terlipressin product containing terlipressin acetate, registered in Ireland by Ferring Ireland Ltd. The same ATC class is registered in 15 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Terlipressin is registered in 15 of 19 countries.
Countries holding a registration under ATC H01BA04 (terlipressin), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 9 of them publish a price we can compare per daily dose
Terlipressin · ATC H01BA04
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Terlipressin acetate
- Manufacturer
- Ferring Ireland Ltd
- Country
- Ireland (IE)
- ATC code
- H01BA04
- ATC class
- Terlipressin
- Defined daily dose
- 12 mg, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1009/004/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Terlipressin in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandGlypressinParanova Oy
- BelgiumGlypressin 1 mgFerring
- CzechiaREMESTYPFerring-Léčiva, a.s., Jesenice u Prahy
- GermanyGlycylpressinFerring Gmbh
- SwedenGlypressin 1 mg Injektionsvätska, lösningFerring Läkemedel AB
- NorwayGlypressinFerring Legemidler AS
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Glycylpressin
- Belgium · Glypressin
- Bulgaria · Реместип
- Germany · Glycylpressin, Terlipressin Aftpharm
- Denmark · Glypressin, Terlipressinacetat Sun
- Estonia · Glypressin
- Spain · Glypressin, Terlipresina Altan
- Finland · Glypressin, Terlipressin Sun
- France · Glypressine, Terlipressine Altan
- United Kingdom (Northern Ireland) · Glypressin, Terlipressin Acetate Aft
- Greece · Glypressin
- Croatia · Glypressin
- Iceland · Glypressin
- Italy · Terlipressina Sun
- Lithuania · Glypressin
- Luxembourg · Glypressin
- Latvia · Glypressin
- Netherlands · Glypressin, Terlipressine Sun
- Norway · Glypressin
- Poland · Glypressin, Terlipressin Acetate Altan
- Portugal · Terlipressina Altan
- Romania · Glypressin
- Sweden · Glypressin, Terlipressin Sun
- Slovenia · Glypressin
- Slovakia · Glypressin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1b4eb19a-bac9-4cf9-b95f-11b6349ef91a GET /v1/drugs/1b4eb19a-bac9-4cf9-b95f-11b6349ef91a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"H01BA",
"H01BA04"
],
"strength": null,
"pa_number": "PA1009/004/001",
"substances": [
"Terlipressin acetate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "09/04/1987",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about terlipressin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.